CannRx has developed patented, breakthrough technologies that will transform the cannabis industry.
Whereas there is a high level of variability within the raw plant material, Cannabis can have a predictable therapeutic effect when formulated properly. Using a scientifically based analytical system designed at CannRx, we produce highly effective, clinically tested products based on cannabis. We have created scientifically driven formulations and products with thorough in vivo testing including testing of over 30 different formulations. The most promising of these has been entered into clinical testing in humans.
CannRx has developed a proprietary formulation that targets sleep disorders. The product has undergone extensive in-vivo trials in predictive pharmaceutical models and demonstrated significantly better efficacy than diazepam, a well-known drug used for sleep and anxiety. CannRx anticipates a multicenter clinical trial in 2019.
CannRx has also performed extensive in vivo testing of a unique formulation for the management of pain. The unique formulation has demonstrated a significant and rapid onset of pain relief. This product is also on target to enter clinical trials in 2019.
In addition to our sleep and pain research, we are developing products targeting:
When the body circulates active compounds in the body, it uses a sophisticated transport system based on circulating proteins that are soluble in the bloodstream. This transport system helps to provide nutrition, pharmaceuticals and other important compounds to our bodies while removing the toxic compounds.
CannRx has replicated this unique process by creating a patented and sophisticated nanoparticle technology to solubilize cannabinoids and terpenes. The process inserts the important cannabis compounds onto these everyday proteins, resulting in highly soluble and stable nanoparticles. The process is natural, clean, efficient and increases bioavailability and ease of formulation, while reducing the dosage necessary for the desired effect.
Solvent-based extraction systems (alcohol, CO2, butane) do not have a long history of use with cannabis and were adapted for the now booming industry. We have designed a completely novel, scientifically driven extraction technology that uses heat to create vapor to generate a cannabinoid profile [which is more therapeutically effective than all other extraction processes]. The VCT increases yield (efficiency of greater than 70%+) removes pesticides and does not require winterization or decarboxylation.